Literature DB >> 30351392

Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis.

Yoshiyuki Abe1, Taiki Ando1, Masakazu Matsushita1, Kurisu Tada1, Ken Yamaji1, Naoto Tamura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30351392     DOI： 10.1093/rheumatology/key310

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.

Authors:  Fatima Bawany; Bushra Tbakhi; Jason H Mendler; Christopher T Richardson; John M Bennett; Omar S Aljitawi
Journal:  Blood Adv       Date:  2020-11-24

2.  Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients.

Authors:  Lijuan Zhao; Shuoshan Xie; Bin Zhou; Chuyu Shen; Liya Li; Weiwei Pi; Zhen Gong; Jing Zhao; Qi Peng; Junyu Zhou; Jiaqi Peng; Yan Zhou; Lingxiao Zou; Liang Song; Honglin Zhu; Hui Luo
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

Review 3.  Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.

Authors:  Aleksandra H Opinc; Joanna S Makowska
Journal:  Biomolecules       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.